GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Deferred Policy Acquisition Costs

Bavarian Nordic A/S (Bavarian Nordic A/S) Deferred Policy Acquisition Costs


View and export this data going back to 2013. Start your Free Trial

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Industry
Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.